Latest Articles on Ebola A Randomized, Blinded, Dose-Ranging Trial of an Ebola Virus Glycoprotein (EBOV GP) Nanoparticle Vaccine with Matrix-M™ Adjuvant in Healthy Adults. Ebola Vaccines: Biomedical Advances, Human Rights Challenges. fShare Tweet ^ Back to Top
